Skip to content

Clinical trials

Phase 4 Pulmonary Disease, Chronic Obstructive trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 4 Country / region: Germany Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20051
20062
20078
20083
20091
20101
20111
20122
20132
20148
20155
20163
20172
20183
20202
20211
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45
Recruiting3
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim12
GlaxoSmithKline11
AstraZeneca8
Novartis Pharmaceuticals7
Aeris Therapeutics1
Air Liquide Santé International1
Bayer1
Chiesi Farmaceutici S.p.A.1
Fraunhofer-Institute of Toxicology and Experimental Medicine1
Hannover Medical School1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive51
Asthma3
Bronchitis, Chronic3
Lung Diseases3
Bronchitis1
Lung Diseases, Obstructive1
Pulmonary Emphysema1
Respiratory Insufficiency1
Respiratory Tract Diseases1

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.